| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,262 |
1,119 |
$61K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
602 |
502 |
$46K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
511 |
429 |
$35K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
289 |
252 |
$22K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
686 |
603 |
$13K |
| 87428 |
|
167 |
160 |
$11K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
114 |
101 |
$10K |
| 90670 |
|
296 |
249 |
$5K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
70 |
68 |
$5K |
| 90648 |
|
260 |
220 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
69 |
67 |
$3K |
| 90686 |
|
174 |
137 |
$3K |
| 90680 |
|
170 |
145 |
$3K |
| 90633 |
|
159 |
137 |
$3K |
| 83655 |
|
207 |
181 |
$2K |
| 90723 |
|
118 |
108 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
95 |
91 |
$1K |
| 90677 |
|
50 |
47 |
$858.44 |
| 87807 |
|
86 |
83 |
$855.10 |
| 87634 |
|
14 |
14 |
$728.00 |
| 90710 |
|
43 |
37 |
$706.08 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
19 |
18 |
$671.27 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
21 |
20 |
$586.82 |
| 90696 |
|
28 |
24 |
$455.43 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
12 |
12 |
$421.08 |
| 85018 |
|
115 |
103 |
$266.80 |